FDA approved radioactive drugs

Ended Awarded Last action

Contract number
75N90021F00001
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Dublin, OH 43017, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$100,000
Original award $100,000

About this award

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $0.00 firm fixed price delivery order to Cardinal Health 414, LLC of Dublin, OH for FDA approved radioactive drugs. As a subsidiary of Cardinal Health, Inc., Cardinal Health 414 will provide the radioactive pharmaceuticals to support research activities at the NIH Clinical Center in Bethesda, MD. No set-aside designation was used for this order placed under an existing vehicle to source these specialized medical products for evaluating new treatments and conducting clinical trials.

Quick answers

Who was awarded contract 75N90021F00001?

75N90021F00001 was awarded to Cardinal Health 414, LLC by NIH Clinical Center (National Institutes of Health) on October 1, 2020.

How much is contract 75N90021F00001 worth?

The government has obligated $0 on 75N90021F00001.

Is contract 75N90021F00001 an order under another contract?

Yes. 75N90021F00001 is a delivery order under 75N90021D00002, an indefinite delivery contract.

Was contract 75N90021F00001 competed?

The extent of competition for 75N90021F00001 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award